Latest Articles

Publication Date
FOCL: Robotic focal therapy drives rapid growth, expanding into new indications and global markets - TradingView

FOCL: Robotic focal therapy drives rapid growth, expanding into new indications and global markets TradingView

Published: June 1, 2026, 4:35 p.m.
Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients - Cancer Therapy Advisor

Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients Cancer Therapy Advisor

Published: May 30, 2026, 4 a.m.
Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients - News-Medical

Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients News-Medical

Published: May 30, 2026, 2:16 a.m.
Pembrolizumab Plus Chemotherapy Shows Sustained Survival in Advanced EC - CancerNetwork

Pembrolizumab Plus Chemotherapy Shows Sustained Survival in Advanced EC CancerNetwork

Published: May 30, 2026, 12:40 a.m.
Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer - OncLive

Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer OncLive

Published: May 29, 2026, 11:57 p.m.
Immunotherapy Addition Demonstrates Sustained Survival Benefits in - Bioengineer.org

Immunotherapy Addition Demonstrates Sustained Survival Benefits in Bioengineer.org

Published: May 29, 2026, 11:56 p.m.
Dostarlimab Plus Chemotherapy Yields Curative Potential in dMMR/MSI-H Endometrial Cancer - CancerNetwork

Dostarlimab Plus Chemotherapy Yields Curative Potential in dMMR/MSI-H Endometrial Cancer CancerNetwork

Published: May 29, 2026, 10:40 p.m.
mRNA Therapy Offers Hope for Uterine Factor Infertility - Technology Networks

mRNA Therapy Offers Hope for Uterine Factor Infertility Technology Networks

Published: May 28, 2026, 2:57 p.m.
Central sensitization in patients with chronic pelvic pain resistant to hormonal therapy: A cross-sectional study of prevalence and clinical correlates in a tertiary referral cohort.

Chronic pelvic pain (CPP) affects over 25% of women, with endometriosis being a predominant cause. Central sensitization, particularly pelvic and perineal pain central sensitization (PPCS), is increasingly recognized as a …

Published: May 28, 2026, midnight
Endometriosis-Associated Ovarian Carcinosarcoma Featuring Well-Differentiated Adenocarcinoma and Fetal Rhabdomyoma-Like Mesenchymal Components: An Unusual Case Report-With Molecular Analysis.

Ovarian carcinosarcoma typically comprises high-grade carcinoma and sarcoma components. We report a case of a woman in her 40s with endometriosis-associated ovarian carcinosarcoma exhibiting an unusual presentation of well-differentiated adenocarcinoma …

Published: May 27, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!